Biopsy analysis of trial S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with anti-PD-1 refractory melanoma

被引：0
|
作者：
Campbell, Katie M.
Bustami, Zaid
Chen, Daniel G.
Medina, Egmidio
Gonzalez, Cynthia R.
Aldeen, Nataly Naser
Baselga-Carretero, Ignacio
Vega-Crespo, Agustin
Maxey, Jessica
Chen, Jia M.
Kuklinski, Lawrence F.
Kendra, Kari L.
Chmielowski, Bartosz
Thach-Giao Truong
Khushalani, Nikhil I.
Collichio, Frances
Ikeguchi, Alexandra
Victor, Adrienne I.
Margolin, Kim
Sosman, Jeffrey A.
Patel, Sapna P.
Hu-Lieskovan, Siwen
Moon, James
Bellasea, Shay
Wells, Daniel K.
Spencer, Christine N.
Thompson, Marshall A.
Wu, Michael
Scumpia, Philip O.
VanderWalde, Ari
Ribas, Antoni
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6550
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6550
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma
    Postow, Michael A.
    Knox, Susan J.
    Goldman, Debra A.
    Elhanati, Yuval
    Mavinkurve, Vikram
    Wong, Phillip
    Halpenny, Darragh
    Reddy, Sunil K.
    Vado, Kenya
    McCabe, Danielle
    Ramirez, Kristen Aufiero
    Macri, Mary
    Schwarzenberger, Paul
    Ricciardi, Toni
    Ryan, Aileen
    Venhaus, Ralph
    Momtaz, Parisa
    Shoushtari, Alexander N.
    Callahan, Margaret K.
    Chapman, Paul B.
    Wolchok, Jedd D.
    Subrahmanyam, Priyanka B.
    Maecker, Holden T.
    Panageas, Katherine S.
    Barker, Christopher A.
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 3193 - 3201
  • [42] Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial
    VanderWalde, Ari
    Bellasea, Shay L.
    Kendra, Kari L.
    Khushalani, Nikhil I.
    Campbell, Katie M.
    Scumpia, Philip O.
    Kuklinski, Lawrence F.
    Collichio, Frances
    Sosman, Jeffrey A.
    Ikeguchi, Alexandra
    Victor, Adrienne I.
    Truong, Thach-Giao
    Chmielowski, Bartosz
    Portnoy, David C.
    Chen, Yuanbin
    Margolin, Kim
    Bane, Charles
    Dasanu, Constantin A.
    Johnson, Douglas B.
    Eroglu, Zeynep
    Chandra, Sunandana
    Medina, Egmidio
    Gonzalez, Cynthia R.
    Baselga-Carretero, Ignacio
    Vega-Crespo, Agustin
    Garcilazo, Ivan Perez
    Sharon, Elad
    Hu-Lieskovan, Siwen
    Patel, Sapna P.
    Grossmann, Kenneth F.
    Moon, James
    Wu, Michael C.
    Ribas, Antoni
    NATURE MEDICINE, 2023, 29 (09) : 2278 - +
  • [43] Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial
    Ari VanderWalde
    Shay L. Bellasea
    Kari L. Kendra
    Nikhil I. Khushalani
    Katie M. Campbell
    Philip O. Scumpia
    Lawrence F. Kuklinski
    Frances Collichio
    Jeffrey A. Sosman
    Alexandra Ikeguchi
    Adrienne I. Victor
    Thach-Giao Truong
    Bartosz Chmielowski
    David C. Portnoy
    Yuanbin Chen
    Kim Margolin
    Charles Bane
    Constantin A. Dasanu
    Douglas B. Johnson
    Zeynep Eroglu
    Sunandana Chandra
    Egmidio Medina
    Cynthia R. Gonzalez
    Ignacio Baselga-Carretero
    Agustin Vega-Crespo
    Ivan Perez Garcilazo
    Elad Sharon
    Siwen Hu-Lieskovan
    Sapna P. Patel
    Kenneth F. Grossmann
    James Moon
    Michael C. Wu
    Antoni Ribas
    Nature Medicine, 2023, 29 : 2278 - 2285
  • [44] Ipilimumab (IPI) alone or in combination with anti-PD-1 (IPI+PD1) in patients (pts) with metastatic melanoma (MM) resistant to PD1 monotherapy.
    Da Silva, Ines Pires
    Ahmed, Tasnia
    Lo, Serigne
    Reijers, Irene L. M.
    Weppler, Alison
    Warner, Allison Betof
    Patrinely, James Randall
    Serra-Bellver, Patricio
    Lebbe, Celeste
    Mangana, Joanna
    Nguyen, Khang
    Zimmer, Lisa
    Ascierto, Paolo Antonio
    Stout, Dan
    Lyle, Megan
    Klein, Oliver
    Gerard, Camille Lea
    Blank, Christian U.
    Menzies, Alexander M.
    Long, Georgina V.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] A retrospective study of ipilimumab plus nivolumab in anti-PD-L1/PD-1-refractory merkel cell carcinoma.
    Shalhout, Sophia Z.
    Emerick, Kevin S.
    Kaufman, Howard E.
    Miller, David M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [46] Infliximab for the Treatment of Ipilimumab (anti CTLA-4) and Nivolumab/Pembrolizumab (anti-PD-1) Associated Colitis
    Sidhu, Mayenaaz
    Mersaides, Antony
    Liniker, Elizabeth
    Tate, David J.
    Nagrial, Adnan
    Long, Georgina
    Sandanayake, Neomal S.
    Kariyawasam, Viraj C.
    Carlino, Matteo S.
    Kwan, Vu
    GASTROENTEROLOGY, 2016, 150 (04) : S803 - S803
  • [47] Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial
    Hodi, F. Stephen
    Chesney, Jason
    Pavlick, Anna C.
    Robert, Caroline
    Grossmann, Kenneth F.
    McDermott, David F.
    Linette, Gerald P.
    Meyer, Nicolas
    Giguere, Jeff Rey K.
    Agarwala, Sanjiv S.
    Shaheen, Montaser
    Ernstoff, Marc S.
    Minor, David R.
    Salama, April K.
    Taylor, Matthew H.
    Ott, Patrick A.
    Horak, Christine
    Gagnier, Paul
    Jiang, Joel
    Wolchok, Jedd D.
    Postow, Michael A.
    LANCET ONCOLOGY, 2016, 17 (11): : 1558 - 1568
  • [48] A phase II trial of nivolumab plus axitinib in patients with anti-PD1 refractory advanced melanoma
    Joshi, Urvashi Mitbander
    Shaikh, Saba
    Zang, Yan
    Wang, Hong
    Sander, Cindy
    Rose, Amy
    Davar, Diwakar
    Luke, Jason J.
    Zarour, Hassane M.
    Kirkwood, John M.
    Delgoffe, Greg M.
    Najjar, Yana G.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] A PHASE II TRIAL OF NIVOLUMAB PLUS AXITINIB IN PATIENTS WITH ANTI-PD1 REFRACTORY ADVANCED MELANOMA
    Shaikh, Saba
    Zang, Yan
    Wang, Hong
    Yang, Xi
    Sander, Cindy
    Rose, Amy
    Davar, Diwakar
    Luke, Jason
    Zarour, Hassane
    Kirkwood, John
    Delgoffe, Greg
    Najjar, Yana
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A265 - A265
  • [50] Ipilimumab in anti-PD1 refractory metastatic melanoma: a report of eight cases
    Jacobsoone-Ulrich, Aurelie
    Jamme, Philippe
    Alkeraye, Salim
    Dzwiniel, Veronique
    Faure, Emmanuel
    Templier, Carole
    Mortier, Laurent
    MELANOMA RESEARCH, 2016, 26 (02) : 153 - 156
12345